VIENNA — The first multicenter randomized trial in gout to compare treat-to-target (T2T) and treat for symptom avoidance (T2S) strategies has finally generated data to make the guideline-recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback